Sign in
Active, not recruitingPhase 3

Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial

Key facts

Who runs it
R-Bio
Where
South Korea4 sites in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
Phase
Phase 3
People taking part
129 people enrolled
Started
13 Apr 2020
Expected to end
30 Dec 2027
Type of study
Interventional
Treatments tested
  • JOINTSTEM
Record updated
10 July 2023

Who can take part

Age
20 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Participants of Jointstem Phase 3 Clinical Trial
  • Participates who signed informed consent document of this study

Who cannot take part

  • No applicable

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this follow-up study is to investigate the efficacy and safety of autologous Adipose Tissue derived Mesenchymal stem cells (JOINTSTEM®) in patient with severe Knee Osteoarthritis.

The group in the trial

  • JOINTSTEMTreatment being tested

    Long Term Follow-up after Jointstem Transplantation

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Long-Term Safety and Efficacy Extension Study Of Autologous Adipose-Derived Mesenchymal Stem Cells 『JOINTSTEM』 in Patients With Knee Osteoarthiritis: A Phase III Extension Study
Publications
Record updated
10 July 2023